1. Home
  2. VALN vs ETJ Comparison

VALN vs ETJ Comparison

Compare VALN & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • ETJ
  • Stock Information
  • Founded
  • VALN 2012
  • ETJ 2007
  • Country
  • VALN France
  • ETJ United States
  • Employees
  • VALN N/A
  • ETJ N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • ETJ Finance Companies
  • Sector
  • VALN Health Care
  • ETJ Finance
  • Exchange
  • VALN Nasdaq
  • ETJ Nasdaq
  • Market Cap
  • VALN 542.5M
  • ETJ 578.8M
  • IPO Year
  • VALN 2021
  • ETJ N/A
  • Fundamental
  • Price
  • VALN $6.59
  • ETJ $8.92
  • Analyst Decision
  • VALN Strong Buy
  • ETJ
  • Analyst Count
  • VALN 3
  • ETJ 0
  • Target Price
  • VALN $15.33
  • ETJ N/A
  • AVG Volume (30 Days)
  • VALN 14.9K
  • ETJ 175.6K
  • Earning Date
  • VALN 08-12-2025
  • ETJ 01-01-0001
  • Dividend Yield
  • VALN N/A
  • ETJ 8.30%
  • EPS Growth
  • VALN N/A
  • ETJ N/A
  • EPS
  • VALN N/A
  • ETJ N/A
  • Revenue
  • VALN $201,099,222.00
  • ETJ N/A
  • Revenue This Year
  • VALN $18.74
  • ETJ N/A
  • Revenue Next Year
  • VALN $29.26
  • ETJ N/A
  • P/E Ratio
  • VALN N/A
  • ETJ N/A
  • Revenue Growth
  • VALN 21.64
  • ETJ N/A
  • 52 Week Low
  • VALN $3.62
  • ETJ $7.20
  • 52 Week High
  • VALN $8.66
  • ETJ $8.47
  • Technical
  • Relative Strength Index (RSI)
  • VALN 72.04
  • ETJ 54.47
  • Support Level
  • VALN $5.82
  • ETJ $8.60
  • Resistance Level
  • VALN $6.19
  • ETJ $9.02
  • Average True Range (ATR)
  • VALN 0.31
  • ETJ 0.07
  • MACD
  • VALN 0.11
  • ETJ -0.01
  • Stochastic Oscillator
  • VALN 100.00
  • ETJ 43.48

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

Share on Social Networks: